\n<\/p>\n
ADMA Biologics, Inc. (NASDAQ:ADMA<\/a>) is one of the Best Growth Stocks to Buy With Highest Upside Potential<\/a><\/strong>. On March 26, Cantor Fitzgerald analyst Kristen Kluska downgraded ADMA Biologics, Inc. (NASDAQ:ADMA) from Overweight to Neutral, without disclosing any price targets.<\/p>\n \u200bThe analyst said in a research note that the main reason behind the downgrade is dissatisfaction with ADMA\u2019s response to allegations of channel stuffing to inflate Asceniv\u2019s revenues. The analyst noted meeting with investors who are disappointed with the company\u2019s lack of direct communication after the report. The firm sought more specific rebuttals to the claims but noted constraints from ADMA\u2019s quiet period. Moreover, some other key financial red flags included rising days sales outstanding and accounts receivable, signaling potential revenue quality issues.<\/p>\n \u200bThe report discussed by Cantor Fitzgerald\u2019s analyst in the research report was by Culper Research that alleged ADMA of boosting 2025 revenue by inducing distributors to stock excess Asceniv via rebates and extended terms, masking an underlying -3% decline.<\/p>\n \u200bADMA Biologics, Inc. (NASDAQ:ADMA) is a biopharmaceutical company that develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.<\/p>\n While we acknowledge the potential of ADMA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the\u00a0best short-term AI stock<\/strong><\/a>.<\/p>\n READ NEXT:\u00a07 Hot Growth Stocks to Invest in Right Now<\/a>\u00a0<\/b>and\u00a07 Ridiculously Cheap Stocks to Buy According to Wall Street Analysts<\/a><\/b>.\u00a0<\/b><\/p>\n Disclosure: None.\u00a0Follow Insider Monkey on Google News<\/b><\/a>.<\/p>\n<\/p><\/div>\n